MedPath

Onkovis GmbH

πŸ‡©πŸ‡ͺGermany
Ownership
-
Employees
-
Market Cap
-
Website

A Non Interventional Study With Oxaliplatin Onkovis (Oxaliplatin) Utilized for the Treatment of Cancer

Completed
Conditions
Carcinoma
First Posted Date
2013-09-13
Last Posted Date
2018-08-07
Lead Sponsor
Onkovis GmbH
Target Recruit Count
383
Registration Number
NCT01942200
Locations
πŸ‡©πŸ‡ͺ

Practice, Naunhof, Germany

A Non Interventional Study With Irinotecan Onkovis (Irinotecan) Utilized for the Treatment of Cancer

Completed
Conditions
Carcinoma
First Posted Date
2013-04-25
Last Posted Date
2018-05-23
Lead Sponsor
Onkovis GmbH
Target Recruit Count
324
Registration Number
NCT01840280
Locations
πŸ‡©πŸ‡ͺ

Practice, Werdau, Germany

A Non Interventional Study With Paclitaxel Onkovis (Paclitaxel) Utilized for the Treatment of Cancer

Completed
Conditions
Carcinoma
First Posted Date
2012-08-17
Last Posted Date
2018-07-16
Lead Sponsor
Onkovis GmbH
Target Recruit Count
770
Registration Number
NCT01668108
Locations
πŸ‡©πŸ‡ͺ

Practice, Plauen, Germany

A Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of Cancer

Completed
Conditions
Carcinoma
First Posted Date
2012-06-07
Last Posted Date
2015-06-04
Lead Sponsor
Onkovis GmbH
Target Recruit Count
371
Registration Number
NCT01614002
Locations
πŸ‡©πŸ‡ͺ

Hospital, Leipzig, Germany

πŸ‡©πŸ‡ͺ

Clinic, Torgau, Germany

πŸ‡©πŸ‡ͺ

Practice, Zwickau, Germany

Β© Copyright 2025. All Rights Reserved by MedPath